Compound 50
Identifiers
- Canonical SMILES:
CN(C)CCC[C@](O)(c1ccccc1)c1cccc(OCc2cccc(c2)-c2ccc(cc2)C(O)=O)c1
- IUPAC name:
4-[3-[[3-[4-(dimethylamino)-1-hydroxy-1-phenylbutyl]phenoxy]methyl]phenyl]benzoic acid
- InChi:
InChI=1S/C32H33NO4/c1-33(2)20-8-19-32(36,28-11-4-3-5-12-28)29-13-7-14-30(22-29)37-23-24-9-6-10-27(21-24)25-15-17-26(18-16-25)31(34)35/h3-7,9-18,21-22,36H,8,19-20,23H2,1-2H3,(H,34,35)/t32-/m0/s1
- InChiKey:
ZEADEHHKYWFCSR-YTTGMZPUSA-N
External links
52943275 |
26361830 |
External search
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
1 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
BCL2-Like / BAX | 4.70 | cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 495.24 g/mol | |||
HBA | 5 | |||
HBD | 2 | |||
HBA + HBD | 7 | |||
AlogP | 3.51 | |||
TPSA | 70.00 | |||
RB | 11 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 1 | 0 | 0 | 0 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.5882 | Ansofaxine | DB15052 | |
0.5726 | Etripamil | DB12605 | |
0.5693 | Adomeglivant | DB11704 | |
0.5556 | Estradiol benzoate | DB13953 | |
0.5500 | Bitolterol | DB00901 | |
0.5454 | Tramadol | DB00193 | |
0.5276 | Cannabinol | DB14737 | |
0.5242 | Mebeverine | DB12554 | |
0.5200 | Cannabivarin | DB14736 | |
0.5159 | KH064 | DB04287 | |
0.5135 | Umeclidinium | DB09076 | |
0.5113 | Meprotixol | DB13822 | |
0.5098 | Terfenadine | DB00342 | |
0.5086 | Ebastine | DB11742 | |
0.5072 | CP-195543 | DB13053 |